Most Recent
Novartis loses bid to remove Pharmacor’s ‘Valtresto’ trade mark
Swiss drug maker Novartis has lost its bid to have Pharmacor's Valtresto trade mark removed for non use, with an IP Australia delegate finding that an injunction in a fight over the patent for Novartis' heart drug Entresto was an obstacle to using the mark. 
In appeal, DC Comics says ‘kryptonite diet’ mark was filed in bad faith
DC Comics is taking another swing at a Sydney man's bid to register 'kryptonite diet' as a trade mark, arguing he acted "willfully blind" or in bad faith in registering the mark given its sizable reputation in the fictional substance from the Superman franchise.
AirTrunk takes rival data centre campus operator to court
Data centre operator AirTrunk has brought court action seeking documents from competitor Zerra DC as its mulls the launch of a possible intellectual property case.
Henkel’s Got2B trade mark got to go for all but hair products
Citing its reputation in Australia, consumer goods giant Henkel has retained its trade mark, 'Got2B', in opposition to a removal bid, but the brand has been narrowed to cover just haircare products.
Mallesons promotes 9 partners across high-demand areas
Mallesons has promoted nine lawyers to its partnership, leaning into its strength as a go-to firm for the country's major banks by promoting four lawyers in its banking and finance practice, in addition to elevating two IP litigators. 
Briefly: Coles, REA, Nine among this week’s litigation targets
Lawyers stuck inside by the dreary, cold weather have been keeping busy penning a slew of new suits targeting the likes of Coles, REA and Nine.
DC Comics won’t let kryptonite trade mark ruling fly
DC Comics is appealing a decision that found 'kryptonite diet' could be registered as a trade mark because the Superman-derived word has become somewhat generic, a ruling that's kryptonite for the Warner Bros-owned company which relies heavily on monetising its IP.
Sneaker brand On Clouds wins appeal in trade mark spat
Popular Swiss sneaker company On Clouds has prevailed in its challenge to a trade mark by sustainable footwear brand Cyclonic.
‘A complete shot in the dark’: AstraZeneca pans Pharmacor defence in Forxiga patent spat
AstraZeneca has slammed Pharmacor's defence to claims it infringed a patent for blockbuster diabetes drug Forxiga as a "complete shot in the dark", as the drug maker unsuccessfully fought orders to produce documents from a UK case.
Shopify sued by designer alleging copyright infringement by ‘ghost stores’
An Australian designer has sued e-commerce giant Shopify, alleging it failed to act when he complained about so-called 'ghost stores' that allegedly copied his designs on almost 4,000 occasions.